A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Marginal Zone Lymphoma

⟵ Back to Search Results

Beigene Study ID

BGB-3111-308

ClinicalTrials.gov ID

NCT05100862

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Locations

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents